Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 4 , Pages 319-330 , July 2010

Investigating activity in hospitalized patients with chronic obstructive pulmonary disease: A pilot study

  • Chris Winkelman, RN, PhD, CCRN

      Affiliations

    • Corresponding Author InformationCorresponding author: Chris Winkelman, RN, PhD, CCRN, Frances Payne Bolton School of Nursing, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106.

References 

  1. Wust RC, Degens H. Factors contributing to muscle wasting and dysfunction in COPD patients. Int J Chron Obstr Pulm Dis. 2007;2:289–300
  2. Rochester CL. Exercise training in chronic obstructive pulmonary disease. J Rehabil Res Dev. 2003;40:59–80
  3. Morris PE. Moving our critically ill patients: mobility barriers and benefits. Crit Care Clin. 2007;23:1–20
  4. Reid MB, Andrade FH, Balke CW, Esser KA. Redox mechanisms of muscle dysfunction in inflammatory disease. Phys Med Rehabil Clin North Am. 2005;16:925–949
  5. Winkelman C. Inactivity and inflammation in the critically ill patient. Crit Care Clin. 2007;23:21–34
  6. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharm Rev. 2004;56:515–548
  7. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J. 2001;18:50s–59s
  8. Vlicek J. The cytokines: an overview. New York: Elsevier; 2003;
  9. Ozaki K, Leonard WJ. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem. 2002;277:29355–29358
  10. Dougherty DE, Briggs DE. Chronic obstructive pulmonary disease: epidemiology, pathogenesis, disease course, and prognosis. Clin Cornerstone. 2004;6(Suppl):S5–S16
  11. Spurzem JR, Rennard SI. Pathognesis of COPD. Semin Respir Crit Care Med. 2005;26:142–153
  12. Kishimoto T. Interleukin-6. New York: Elsevier; 2003;
  13. Reid PT, Sallenave J-M. Cytokines in the pathogenesis of chronic obstructive pulmonary disease. Curr Pharm Des. 2003;9:25–38
  14. Roth M. Pathogenesis of COPD. Part III. Inflammation in COPD. Int J Tuberc Lung Dis. 2008;12:375–380
  15. Riley DA, Allin EF. The effect of inactivity, programmed stimulation, and denervation on the histochemistry of skeletal muscle fiber types. Exp Neurol. 1973;40:391–413
  16. Larsen AI, Lindal S, Aukrust P, Toft I, Aarsland T, Dickstein K. Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity. Int J Cardiol. 2002;83:25–32
  17. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Crit Care Med. 2001;164:1414–1418
  18. van Helvoort HAC, Heijdra YF, de Boer RCC, Swinkelms A, Thijs HMH, Dekhuijjsen R. Six-minute walking-induced systemic inflammation and oxidative stress in muscle-wasted COPD patients. Chest. 2008;131:439–445
  19. Vogiatzis I, Stratakos G, Simoes DCM, et al. Effects of rehabilitative exercise on peripheral muscle TNFa, IL-6, IGF-I and MyoD expression of patients with COPD. Thorax. 2007;62:950–956
  20. Ding Y-Z, Fu S, Szamarin D, Bromberg J. Interleukin-10. New York: Elsevier; 2003;
  21. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol (London). 2004;515:287–291
  22. Smith DA, Irving SD, Sheldon J, Cole D, Kaski JC. Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation. 2001;104:756–761
  23. Long P, Gassner R, Argarwal S. Tumor necrosis factor a-dependent proinflammatory gene induction is inhibited by cyclic tensile strain in articular chondrocytes in vitro. Arthritis Rheum. 2001;44:2311–2319
  24. Malm C. Exercise induces muscle damage and inflammation—fact or fiction?. Acta Physiol Scand. 2001;171:233–239
  25. Starkweather AR. The effects of exercise on perceived stress and IL-6 levels among older adults. Biol Res Nurs. 2007;8:186–194
  26. Winkelman C, Higgins PA, Chen Y-JK, Levin A. Cytokines in chronically critically ill patients after activity and rest. Biol Res Nurs. 2007;8:261–271
  27. Reid MB, Li Y-P. Tumor necrosis factor-a and muscle wasting: a cellular perspective. Respir Res. 2001;2:269–272
  28. Seifert C, Dempfle A, Plagens A, et al. TNF-alpha, TNF-beta, IL-6 and IL-10 promoter polymorphisms in patients with chronic obstructive pulmonary disease. Tissue Antigens. 2005;65:93–100
  29. Gallagher OM, Lowe G, Fitzgerald T, et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax. 2003;58:154–156
  30. Opal SM, Huber CE. The role of interleukin-10 in critical illness. Curr Opin Infect Dis. 2000;13:221–226
  31. Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein among US adults. Epidemiology. 2002;13:561–568
  32. Kelley GA, Kelley KS. Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials. Metabolism. 2006;55:1500–1507
  33. Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sport. 2006;16:3–63
  34. Plaisance EP, Grandjean PW. Physical activity and high-sensitivity C-reactive protein. Sports Med. 2006;35:443–458
  35. Fischer CP, Bernsten A, Perstrup LB, Eskildsen P, Pedersen BK. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sport. 2007;17:580–587
  36. Green GB, Harris IS, Lin GA, Moylan KC. The Washington manual. St. Louis: Lippincott Williams & Wilkins; 2004;
  37. Rhodes SG, Graham SP. Is “timing” important for cytokine polarization?. Trends Immunol. 2002;23:246–249
  38. Pedersen BK. Exercise and cytokines. Immunol Cell Biol. 2000;78:532–535
  39. Knaus W, Wagner D, Draper E, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619–1636
  40. Knebel AR, Shekelton ME, Burns S, Clochesy JM, Goodnough SK, Ingersoll GL. Weaning from mechanical ventilatory support: refinement of a model. Am J Crit Care. 1998;7:149–152
  41. Hall C, Body L. Therapeutic exercise: moving toward function. Philadelphia: Lippincott; 1999;
  42. Lane L, Winslow E, Wood RJ, Dixon J. Dangling practices of 51 nurses: a pilot project. Am J Crit Care. 1991;6:177–182
  43. Tyron W. Activity measurement in psychology and medicine. New York: Plenum Press; 1991;
  44. Bauldoff GS, Ryan-Wegner NA, Diaz PT. Wrist actigraphy validation of exercise movement in COPD. Wet J Nurs Res. 2007;29:789–802
  45. Winkelman C, Higgins PA, Chen Y-JK. Measuring activity in the chronically critically ill. Dimens Crit Care Nurs. 2005;24:281–290
  46. Grap MJ, Borchers CT, Munro CL, Elswick RK, Sessler CN. Actigraphy in the critically ill: correlations with activity, agitation, and sedation. Am J Crit Care. 2005;14:52–63
  47. Vogiatzis I, Stratakos G, Simoes DCM, et al. Effects of rehabilitative exercise on peripheral muscle TNFa, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax. 2007;62:950–956
  48. Koechlin C, Couillard A, Cristol JP, et al. Does systemic inflammation trigger local exercise-induced oxidative stress in COPD?. Eur Respir J. 2004;23:538–544
  49. Ionescu AA, Micklebourough TD, Lindley MR, et al. Enhanced cytokine response to exercise in COPD. In: European Respiratory Society Annual Congress held in Munich. Lausanne, Switzerland: Nonin Medical, Inc; 2006;p. 758
  50. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis. 2000;181:176–180
  51. Nevzorova A, Barkhatova A, Dochetkova A. Content of IL-6, IL-10 and TNFa in blood of COPD patients depending on body mass. In: European Respiratory Society Annual Congress held in Munich. Lausanne, Switzerland: Nonin Medical, Inc; 2006;p. 761
  52. Petersen AMW, Penkova M, Iverson M, et al. Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung. 2007;185:161–171
  53. Rabinovich RA, Figueras M, Ardite E, et al. Increased tumor-necrosis factor-a plasma levels during moderate-intensity exercise in COPD patients. Eur Respir J. 2003;21:789–794
  54. Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eur Medicophys. 2007;43:475–485
  55. Dolansky MA, Moore SM. Older adults' early disability following a cardiac event. West J Nurs Res. 2008;30:163–180
  56. Hill AT, Bayley D, Stockley TA. The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. Am J Respir Crit Care Med. 1999;160:893–898
  57. Barnett M. Using a model in the assessment and management of COPD. 4,6 J Community Nurs. 2007;21:8–10
  58. Gross NJ. Outcome measures for COPD treatments: a critical evaluation. COPD. 2004;1:41–57

 This work was supported by the American Association of Critical Care Nurses, the Ohio Nurses Foundation, and the MetroHealth General Clinical Research Center (grant GCRC M01RR000080).

PII: S0147-9563(09)00234-9

doi: 10.1016/j.hrtlng.2009.09.004

Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 4 , Pages 319-330 , July 2010

Article Tools

* Image Usage & Resolution